Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Deborah E. Glotzer"'
Autor:
Deborah E. Glotzer, Michael Weitzman
Publikováno v:
Pediatric Annals. 24:630-639
Publikováno v:
Pediatrics. 95:331-334
Objective. To assess the information needs of parents regarding childhood immunizations, and their satisfaction with the Vaccine Information Pamphlets (VIPs). Research design. Verbally administered, forced-choice survey of a representative sample. Se
Publikováno v:
Medical Decision Making. 15:13-23
Objectives. No consensus exists regarding the preferred treatment of childhood lead poi soning. The authors used decision analysis to compare the clinical impacts and cost-ef fectiveness of four management strategies for childhood lead poisoning, and
Autor:
Deborah E. Glotzer
Publikováno v:
Pediatric Annals. 23:606-615
Autor:
Deborah E. Glotzer, Howard Bauchner
Publikováno v:
Pediatrics. 89:614-618
Published recommendations (1985) for the management of childhood lead poisoning suggest the use of ethylenediaminetetraacetic acid (EDTA)provocation testing and chelation as the mainstay of treatment for blood lead levels between 25 and 55 μg/dL. Si
Autor:
John R. Knight, Lon Sherritt, Judith S. Shaw, Nohelani Lawrence, Deborah E. Glotzer, Sion Kim Harris, Celeste R. Wilson
Publikováno v:
Pediatrics. 122(5)
OBJECTIVES. Pediatricians are in an ideal position to screen parents of their patients for alcohol use. The objective of this study was to assess parents’ preferences regarding screening and intervention for parental alcohol use during pediatric of
Publikováno v:
American Journal of Public Health. 84:110-112
Decision analysis was used to compare the costs of three screening strategies for childhood lead poisoning: (1) venipuncture; (2) capillary sample with venipuncture confirmation if the blood lead level is elevated; (3) stratification by risk, with ve
The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning
Autor:
Deborah E. Glotzer
Publikováno v:
Drug safety. 9(2)
2,3-Dimercaptosuccinic acid (DMSA) is an orally active chelating agent used in the treatment of lead and other heavy metal poisonings. In animals, DMSA chelates lead from soft tissues, including the brain, without clinically evident adverse effects o